retatrutide weight loss results clinical trial Shows 28% in 80 Weeks eli lilly retatrutide trial results

It affects whether patients can stay consistent, eat enough protein, build strength, keep follow-up visits, avoid abrupt stopping, and maintain progress after the active weight-loss phase slows

Many insurance plans require prior authorization before they will cover weight loss medications

Originally used to treat diabetes, GLP-1s have become an attractive option for those looking to suppress hunger and shed pounds fast

Additionally, all participants were classified as obese

The interplay between hormonal conditions and microbiome manipulation is not well enough understood to make blanket recommendations

GLP-1 diabetes and weight-loss drug side effects: Harvard Health